三葉草生物製藥(02197.HK)附屬租用上海辦公室
三葉草生物製藥(02197.HK)公布,間接全資附屬上海愷洛菲,與上海品佳生就租賃該等物業訂立租賃協議,用作辦公室及研發實驗室,期自2022年5月1日起最多8年,上海愷洛菲及上海品佳生將至少於期限第五年結束前六個月確認是否將於期限餘下的三年內繼續履行租賃協議。
該等物業為上海市浦東新區蔡倫路255號1號樓部分區域、3號樓、4號樓、5號樓及6號樓整幢,可出租總面積約為約2.6萬平方米。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.